Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines

Prostaglandins and Other Lipid Mediators

Volumn 71, Issue 3-4, 2003, Pages 177-188

  Heyd, V L ^a   Eynard, A R ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Anti tumour activities; Eicosatrienoic acid; Fatty acids; Human cancer cell lines

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ESSENTIAL FATTY ACID; FATTY ACID; ICOSAPENTAENOIC ACID; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPID PEROXIDATION; METASTASIS; MITOSIS INHIBITION; PROTEIN EXPRESSION; TUMOR GROWTH; UROGENITAL TRACT TUMOR;

EID: 0041707862     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-8823(03)00037-6     Document Type: Article

References (29)

1. Jiang W.G., Hiscox S., Hallet M.B., Horrobin D.F., Scott C., Puntis M.C.A. Inhibition of invasion and motility of human colon cancer cells by gamma-linoleic acid. Br. J. Cancer. 71:1995;744-752.
2. Jiang W.G., Bryce R.P., Horrobin D.F. Essential fatty acids: molecular and cellular basic of their anti-cancer action and clinical implication. Crit. Rev. Oncol. Hematol. 27:1998;179-209.
3. Monjabez A.M., Clay C.E., High K.P., Hilton F.H. Antineoplastic properties of arachidonic acid and its metabolite. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;5-12.
4. Cabre E., Gasull M.A. Polyunsaturated fatty acid deficiency in liver diseases. Pathophysiological and clinical significance. Nutrition. 12:1996;542-548.
5. Mead J.F. The essential fatty acids: past, present, future. Prog. Lip. Res. 20:1981;1-6.
6. Eynard A.R. Role of dietary polyunsaturated acids (PUFA) on tumorigenesis. Cancer J. 9:1996;142-144.
7. Eynard AR. Does chronic essential fatty acids deficiency (EFAD) constitute a protumorigenic condition? Med Hypotheses 1997;48:55-62.
8. Eynard A.R., Jiang W.G., Mansel R.E. Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro. Prostaglandins Leukot. Essent. Fatty Acids. 59:1998;371-377.
9. Horrobin D.F. Is the main problem in free radical damage caused by radiation, oxygen and other toxins the loss of membrane essential fatty acids rather than the accumulation of toxic materials? Med. Hypotheses. 35:1991;23-26.
10. Bridges R.B., Coniglio J.G. The biosynthesis of Δ 9, 12, 15, 18-tetracosapentaenoic acid and Δ 6, 9, 12, 15, 18-tetracosapentaenoic acids by rat testes. J. Biol. Chem. 245:1970;46-49.
11. Folch J., Lees M., Sloane Stanley G.H. A simple method for the Isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
12. Calderon R.O., Glocker M.T., Eynard A.R. Lipids and fatty acid composition of different fractions from rat urinary transitional epithelium. Lipids. 33:1998;1017-1022.
13. Pasqualini M.E., Heyd V.L., Manzo P., Eynard A.R. Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE:15-HETE ratio. A possible role of their metastatic potential. Prostaglandins Leukot. Essent. Fatty Acids. 68:2002;9-16.
14. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265.
16. Carmichael J.D.E., Graff W.G., Gazdar A.F., Minna J.B. Evaluation of a tetrazolium-base semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
17. Anuradha C.D., Kanno S., Hirano S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radic. Biol. Med. 31:2001;367-373.
18. Gonzales M.J., Schemmel R.A., Dugan L.et al. Dietary fish-oil inhibits human breast-carcinoma growth - a function of increased lipid-peroxidation. Lipids. 28:1993;827-832.
19. Carruthers A., Melchior D.L. How bilayer lipids affect membrane protein activity. Trends Biochem. Sci. 11:1986;331-335.
20. Rose D.P., Connoly J.M., Meschter C.L. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J. Natl. Cancer Inst. 83:1991;1491-1495.
21. Das U.N., Prasad V.V.K., Reddy D.R. Local application of gamma-linolenic acid in the treatment of human glioma. Cancer Lett. 94:1995;147-155.
22. Leaver H.A., Bell H.S., Rizzo M.T., Ironside J.W., Gregor A., Wharton S.B.et al. Antitumour and pro-apoptotic actions on highly unsaturated fatty acids in glioma. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;1929.
23. Bakshi A, Mukherjee D, Banerji AK, et al. Gamma-linoleic acids therapy of human gliomas. Nutrition 2003;19:305-9.
24. Newman M.J. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acid. Proc. Natl. Acad. Sci. USA. 87:1990;5543-5547.
25. Begin M.E., Ells G., Horrobin D.F. Polynsaturated fatty acid-induced cytotoxity against tumour cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst. 80:1988;188-194.
26. Jiang WG, Redfern A, Eynard AR, Mansel RE. Polyunsaturated fatty acids and their role in cancer invasion and metastasis. In: Cancer metastasis, molecular and cellular mechanism and clinical implication; 2000 [chapter 9]. p. 225-50.
27. Takechi M. Cadherins in cancer: implication for invasion and metastasis. Curr. Opin. Cell Biol. 5:1993;806-811.
28. Jiang W.G., Eynard A.R., Mansel R.E. The pathology of essential fatty acid deficiency: is it cell adhesion mediated? Med. Hypotheses. 55:2000;257-262.
29. Eynard AR. The potential of essential fatty acids as natural therapeutic products of human tumours. Nutrition 2003;19:387-9.